Absci Ownership | Who Owns Absci?
Absci Ownership Summary
Absci is owned by 65.01% institutional investors, 13.05% insiders, and 21.95% retail investors. Fmr is the largest institutional shareholder, holding 16.49% of ABSI shares. ARK Genomic Revolution ETF is the top mutual fund, with 7.64% of its assets in Absci shares.
ABSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Absci | 65.01% | 13.05% | 21.95% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 22.55M | 16.49% | $67.65M |
| Ark investment management | 13.73M | 10.04% | $41.18M |
| Blackrock funding, inc. /de | 11.26M | 8.23% | $33.77M |
| Redmile group | 8.25M | 6.03% | $24.76M |
| Vanguard group | 7.91M | 5.50% | $27.61M |
| Blackrock | 5.34M | 5.38% | $16.46M |
| State street | 7.32M | 5.36% | $21.97M |
| Advanced micro devices | 5.71M | 4.18% | $17.14M |
| Geode capital management | 3.34M | 2.44% | $10.03M |
| Woodline partners lp | 3.30M | 2.41% | $9.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Advanced micro devices | 5.71M | 9.83% | $17.14M |
| Gem investment advisors | 2.17M | 6.40% | $6.51M |
| Redmile group | 8.25M | 1.64% | $24.76M |
| Great point partners | 796.44K | 1.00% | $2.42M |
| Parkman healthcare partners | 1.86M | 0.58% | $5.59M |
| Ark investment management | 13.73M | 0.32% | $41.18M |
| Casdin capital | 973.26K | 0.22% | $2.92M |
| Platinum investment management | 237.76K | 0.18% | $713.29K |
| Pier 88 investment partners | 206.10K | 0.15% | $618.30K |
| Siren | 1.80M | 0.15% | $5.40M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 5.34M | 0.00% | 4.45M |
| Siren | 1.80M | 0.15% | 1.80M |
| Two sigma investments, lp | 2.90M | 0.01% | 1.48M |
| State street | 7.32M | 0.00% | 1.33M |
| Marshall wace, llp | 1.22M | 0.00% | 1.22M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 117.56K | - | -2.04M |
| Schonfeld strategic advisors | 332.26K | 0.01% | -2.02M |
| Citadel advisors | 404.42K | 0.00% | -1.54M |
| Laurion capital management lp | - | - | -1.19M |
| Ubs group | 1.60M | 0.00% | -1.10M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Siren | 1.80M | 0.15% | 1.80M | $5.40M |
| Marshall wace, llp | 1.22M | 0.00% | 1.22M | $3.66M |
| Balyasny asset management | 1.05M | 0.00% | 1.05M | $3.14M |
| Vanguard fiduciary trust | 951.45K | 0.00% | 951.45K | $2.85M |
| Great point partners | 796.44K | 1.00% | 796.44K | $2.42M |
Sold Out
| Holder | Change |
|---|---|
| Pineridge advisors | -1.00 |
| Federated hermes | -3.00 |
| Capital performance advisors llp | -11.00 |
| Riggs asset managment | -78.00 |
| Mendota financial group | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 133 | -10.74% | 88,914,683 | -27.17% | 65 | 0.90% | 73 | - | 30 | -9.09% |
| Dec 31, 2025 | 40 | -73.15% | 14,828,343 | -84.67% | 10 | 0.18% | 16 | -80.00% | 7 | -79.41% |
| Sep 30, 2025 | 52 | -61.48% | 14,647,739 | -83.64% | 11 | 0.23% | 24 | -67.12% | 8 | -76.47% |
| Jun 30, 2025 | 134 | -8.22% | 89,499,197 | 4.64% | 70 | 1.49% | 72 | -14.29% | 34 | - |
| Mar 31, 2025 | 146 | 7.35% | 85,529,834 | 15.75% | 68 | 1.62% | 85 | 8.97% | 33 | 6.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 11.88M | 7.64% | 502.60K |
| ARK Genomic Revolution | 11.20M | 7.32% | -344.64K |
| Fidelity Growth Compy Commingled Pl S | 9.94M | 6.38% | 14.45K |
| Fidelity Growth Compy Commingled Pl O | 5.75M | 5.06% | - |
| Fidelity Growth Company Fund | 6.91M | 4.45% | - |
| State Street® SPDR® S&P® Biotech ETF | 5.05M | 3.25% | -49.92K |
| Vanguard Total Stock Mkt Idx Inv | 4.25M | 2.73% | - |
| iShares Russell 2000 ETF | 3.20M | 2.05% | 26.93K |
| Columbia Acorn Inst | 2.89M | 1.85% | 322.22K |
| Alger Small Cap Focus I | 2.47M | 1.65% | -290.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 13, 2026 | Pangalos Menelas N | - | Buy | $200.75K |
| Mar 12, 2026 | Busch Andreas | Chief Innovation Officer | Buy | $229.00K |
| Feb 27, 2026 | Pangalos Menelas N | - | Buy | $205.76K |
| Feb 02, 2026 | McClain Sean | Chief Executive Officer | Sell | $80.02K |
| Feb 02, 2026 | Jonasson Zachariah | CFO / CBO | Sell | $52.31K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | - |
| 2026 Q1 | 2 | 2 |
| 2025 Q4 | 1 | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | - |
ABSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools